Robert Burns
Stock Analyst at HC Wainwright & Co.
(3.04)
# 1,292
Out of 5,116 analysts
481
Total ratings
39.37%
Success rate
2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLX Telix Pharmaceuticals | Reiterates: Buy | $20 | $8.03 | +149.07% | 3 | Dec 22, 2025 | |
| NUVB Nuvation Bio | Maintains: Buy | $10 → $18 | $9.40 | +91.49% | 17 | Dec 11, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $28 → $31 | $19.30 | +60.62% | 20 | Dec 10, 2025 | |
| IMMX Immix Biopharma | Maintains: Buy | $8 → $12 | $5.64 | +112.77% | 10 | Dec 9, 2025 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $24 → $26 | $10.37 | +150.72% | 3 | Nov 20, 2025 | |
| ZYME Zymeworks | Maintains: Buy | $26 → $32 | $26.87 | +19.09% | 23 | Nov 18, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $19 → $23 | $8.25 | +178.79% | 26 | Nov 14, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $21 → $50 | $38.88 | +28.60% | 15 | Nov 13, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $136 → $140 | $94.52 | +48.12% | 46 | Nov 10, 2025 | |
| ACET Adicet Bio | Maintains: Buy | $4 → $9 | $0.52 | +1,630.77% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $80.75 | -9.60% | 21 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $49 | $46.24 | +5.97% | 11 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $9 | $1.70 | +429.41% | 15 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $2 | $1.61 | +24.22% | 22 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.00 | +400.00% | 8 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $2.57 | +16.73% | 19 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 | $9.96 | +20.48% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7 | $5.33 | +31.33% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.51 | +99.43% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $7.44 | +101.61% | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.88 | +247.22% | 5 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.45 | +104.08% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $12.33 | +118.98% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $2.80 | +1,114.29% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $8.56 | +63.55% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $16.80 | +138.10% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $21.97 | +91.17% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $2.59 | +286.10% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $3.17 | +215.46% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $8.07 | +61.09% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $16.30 | +194.48% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $0.80 | +1,407.92% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $8.67 | +49.94% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.24 | +303.23% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.38 | +479.71% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $17.27 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $20.00 | +900.00% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.24 | +19,254.84% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.83 | +17,920.18% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.39 | +150.57% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $3.31 | +1,359,416.62% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.23 | +491.02% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.67 | +678.44% | 1 | Jan 7, 2021 |
Telix Pharmaceuticals
Dec 22, 2025
Reiterates: Buy
Price Target: $20
Current: $8.03
Upside: +149.07%
Nuvation Bio
Dec 11, 2025
Maintains: Buy
Price Target: $10 → $18
Current: $9.40
Upside: +91.49%
Nurix Therapeutics
Dec 10, 2025
Maintains: Buy
Price Target: $28 → $31
Current: $19.30
Upside: +60.62%
Immix Biopharma
Dec 9, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $5.64
Upside: +112.77%
Cullinan Therapeutics
Nov 20, 2025
Maintains: Buy
Price Target: $24 → $26
Current: $10.37
Upside: +150.72%
Zymeworks
Nov 18, 2025
Maintains: Buy
Price Target: $26 → $32
Current: $26.87
Upside: +19.09%
ORIC Pharmaceuticals
Nov 14, 2025
Maintains: Buy
Price Target: $19 → $23
Current: $8.25
Upside: +178.79%
Cogent Biosciences
Nov 13, 2025
Maintains: Buy
Price Target: $21 → $50
Current: $38.88
Upside: +28.60%
BioNTech SE
Nov 10, 2025
Maintains: Buy
Price Target: $136 → $140
Current: $94.52
Upside: +48.12%
Adicet Bio
Nov 7, 2025
Maintains: Buy
Price Target: $4 → $9
Current: $0.52
Upside: +1,630.77%
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $80.75
Upside: -9.60%
Nov 5, 2025
Maintains: Buy
Price Target: $46 → $49
Current: $46.24
Upside: +5.97%
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $1.70
Upside: +429.41%
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.61
Upside: +24.22%
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.00
Upside: +400.00%
Oct 27, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $2.57
Upside: +16.73%
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $9.96
Upside: +20.48%
Oct 20, 2025
Assumes: Buy
Price Target: $7
Current: $5.33
Upside: +31.33%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.51
Upside: +99.43%
Oct 13, 2025
Upgrades: Buy
Price Target: $15
Current: $7.44
Upside: +101.61%
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $2.88
Upside: +247.22%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $2.45
Upside: +104.08%
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $12.33
Upside: +118.98%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $2.80
Upside: +1,114.29%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $8.56
Upside: +63.55%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $16.80
Upside: +138.10%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $21.97
Upside: +91.17%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.59
Upside: +286.10%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $3.17
Upside: +215.46%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $8.07
Upside: +61.09%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $16.30
Upside: +194.48%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $0.80
Upside: +1,407.92%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $8.67
Upside: +49.94%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.24
Upside: +303.23%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.38
Upside: +479.71%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $17.27
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $20.00
Upside: +900.00%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.24
Upside: +19,254.84%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.83
Upside: +17,920.18%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.39
Upside: +150.57%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $3.31
Upside: +1,359,416.62%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.23
Upside: +491.02%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.67
Upside: +678.44%